An Exploratory Study of Sunitinib (SU) Plus Docetaxel (D) and Trastuzumab (T) for First-Line Therapy of HER2+Advanced Breast Cancer (ABC).

被引：0

作者：

Dirix, L.

Canon, J. L.

Amadori, D.

Villa, E.

Aldrighetti, D.

Machiels, J. P.

Verkh, L.

Bouko, Y.

Kem, K.

Giorgetti, C.

Cardoso, F.

机构：

[1] AZ ST Augustinus, Antwerp, Belgium

[2] Grand Hop Charleroi, Charleroi, Belgium

[3] IRST, Meldola, Italy

[4] San Raffaele, Milan, Italy

[5] Univ Catholique Louvain, B-1200 Brussels, Belgium

[6] Pfizer Oncol, La Jolla, CA USA

[7] Pfizer Oncol, Milan, Italy

[8] Inst Jules Bordet, B-1000 Brussels, Belgium

来源：

CANCER RESEARCH | 2009年 / 69卷 / 24期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：852S / 853S

页数：2

共 50 条

[41] An Evaluation of the Safety and Efficacy of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2+Metastatic Breast Cancer [J].

Esteva, F. J. ;

Franco, S. X. ;

Hagan, M. K. ;

Somer, R. A. ;

Dombroski, C. S. ;

Florance, A. M. ;

Turner, S. J. ;

Stein, S. ;

Perez, A. .

CANCER RESEARCH, 2009, 69 (24) :793S-793S

[42] Preliminary results of a phase I study of sunitinib plus paclitaxel for first-line treatment of advanced breast cancer [J].

Kozloff, Mark ;

Chuang, Ellen ;

Roy, Jessica ;

Starr, Alexander ;

Gowland, Patricia A. ;

Tarpey, Matthew J. ;

Collier, Mary ;

Verkh, Lev ;

Kern, Kenneth ;

Miller, Kathy .

MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) :3591S-3591S

[43] Safety and efficacy of the combination of trastuzumab plus capecitabine and docetaxel as first-line therapy for metastatic breast cancer: phase II results [J].

Michalaki, V. ;

Gennatas, S. ;

Gennatas, C. .

EJC SUPPLEMENTS, 2009, 7 (02) :276-276

[44] Preliminary results of a phase I study of sunitinib plus paclitaxel for first-line treatment of advanced breast cancer [J].

Kozloff, M. ;

Chuang, E. ;

Roy, J. ;

Starr, A. ;

Gowland, P. A. ;

Tarpey, M. J. ;

Collier, M. ;

Verkh, L. ;

Kern, K. ;

Miller, K. .

EJC SUPPLEMENTS, 2007, 5 (04) :216-216

[45] MonarcHER: A randomized phase II study of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+advanced breast cancer (ABC) [J].

Tolaney, S. M. ;

Wardley, A. M. ;

Zambelli, S. ;

Hilton, J. ;

Troso-Sandoval, T. ;

Ricci, F. ;

Im, S-A. ;

Kim, S-B. ;

Johnston, S. R. D. ;

Chan, A. ;

Goel, S. ;

Catron, K. ;

Yang, Z. ;

Gainford, C. ;

Andre, F. .

ANNALS OF ONCOLOGY, 2019, 30 :861-+

[46] Trastuzumab (Herceptin®) plus docetaxel versus docetaxel alone as first-line treatment of HER2-positive metastatic breast cancer (MBC):: results of a randomised multicentre trial [J].

Extra, J. M. ;

Cognetti, F. ;

Maraninch, D. ;

Snyder, R. ;

Mauriac, L. ;

Tubiana-Hulin, M. ;

Chan, S. ;

Grimes, D. ;

Anton, A. ;

Marty, M. .

EJC SUPPLEMENTS, 2004, 2 (03) :125-126

[47] Sunitinib (SU) in Combination with Trastuzumab (T) for the Treatment of Advanced Breast Cancer (ABC): Activity and Safety Results from a Phase II Study. [J].

Blay, J-Y ;

Lluch, A. ;

Gutierrez, M. ;

Martin, M. ;

Kozloff, M. F. ;

Prady, C. ;

Huang, X. ;

Verkh, L. ;

Chen, C. ;

Tassell, V ;

Kern, K. ;

Verma, S. .

CANCER RESEARCH, 2009, 69 (24) :510S-510S

[48] Docetaxel and mitoxantrone, versus docetaxel mitoxantrone and letrozole as first-line therapy in advanced breast cancer: A randomized study. [J].

Gennatas, C ;

Mouratidou, D ;

Tsavaris, N ;

Michalaki, V ;

Psychogios, J ;

Poulakaki, N ;

Andreadis, C ;

Diamantopoulos, N ;

Gennatas, S .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :58S-58S

[49] Efficacy and tolerability of first-line anti-HER2 therapy for HER2+advanced breast cancer: A single-centre real-world experience. [J].

Battisti, Nicolo Matteo Luca ;

Okonji, David Odhiambo ;

Redana, Stefania ;

Chaabouni, Narda ;

Fong, Caroline ;

Mohammed, Kabir ;

Allen, Mark ;

Ring, Alistair E. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[50] First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study [J].

Bergh, Jonas ;

Bondarenko, Igor M. ;

Lichinitser, Mikhail R. ;

Liljegren, Annelie ;

Greil, Richard ;

Voytko, Nataliya L. ;

Makhson, Anatoly N. ;

Cortes, Javier ;

Lortholary, Alain ;

Bischoff, Joachim ;

Chan, Arlene ;

Delaloge, Suzette ;

Huang, Xin ;

Kern, Kenneth A. ;

Giorgetti, Carla .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (09) :921-929

← 1 2 3 4 5 →